LLY compared with OVID: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

OVIDOvid Therapeutics Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

OVIDOvid Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25· pre 1,422.25· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

OVIDOvid Therapeutics Inc.

2.40· pre 2.44· delayed

Pre-marketNov 4 '26delayed

Mkt cap$468.7MRevenue$733,000Q2 FY26Revenue$7MFY25

Compare

Pre-marketNov 4 '26delayed

LLYELI Lilly & Co

OVIDOvid Therapeutics Inc.

1,407.25pre 1,422.25delayed

Price

2.40pre 2.44delayed

$1.3T

Mkt cap

$468.7M

Q3 FY26$24.4B

Revenue

$733,000Q2 FY26

FY25$65.2B

Revenue

$7MFY25

LLY1,407.25vsOVID2.40Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

LLY, solidOVID, dashed

Supply-chain overlap

Revenue flow

OVID: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only OVID 7

LGNDLigand Pharmaceuticalscustomer

TAKTakedacustomer

—Northwestern Universityunlistedsupplier

—AstraZeneca

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

3 more · OVID chain ›